UBLITUXIMAB-XIIY for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 18 adverse event reports in the FDA FAERS database where UBLITUXIMAB-XIIY was used for Relapsing-remitting multiple sclerosis.

Most Reported Side Effects for UBLITUXIMAB-XIIY

Side Effect	Reports	%	Deaths	Hosp.
Infusion related reaction	481	53.4%	0	18
Fatigue	48	5.3%	0	2
Headache	34	3.8%	0	3
Malaise	22	2.4%	0	0
Inappropriate schedule of product administration	21	2.3%	0	0
Product dose omission issue	19	2.1%	0	1
Asthenia	18	2.0%	1	3
Drug ineffective	18	2.0%	1	0
Nausea	18	2.0%	1	2
Dizziness	17	1.9%	1	1
Covid-19	16	1.8%	0	1
Off label use	16	1.8%	0	1
Pyrexia	16	1.8%	0	1
Urinary tract infection	16	1.8%	0	3
Back pain	15	1.7%	0	0